Dow Down 0.06% Nasdaq Down 0.18%

More On ACEL

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Tamir Biotechnology, Inc. (ACEL)

-Other OTC
0.05 0.00(0.00%) Jun 19
Prev Close:0.05
Open:0.05
Bid:N/A
Ask:N/A
1y Target Est:7.00
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.01 - 0.08
Volume:0
Avg Vol (3m):9,403
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ACEL at this time.

Comparison

Symbol% ChgMkt Cap
ACEL 0.00%N/A
LLYDown 0.02%67.30B
IMGNDown 2.05%1.02B
MRKUp 0.20%174.00B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jul-08) :N/A
Quarterly EPS Est (Jul-08) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Tamir Biotechnology, Inc., a biopharmaceutical company, primarily engages in the discovery and development of a class of therapeutic drugs for the treatment of cancer and other pathological conditions. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback